Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Health Data in Dentistry: An Attempt to Master the Digital Challenge.

Joda T, Waltimo T, Probst-Hensch N, Pauli-Magnus C, Zitzmann NU.

Public Health Genomics. 2019;22(1-2):1-7. doi: 10.1159/000501643. Epub 2019 Aug 7. Review.

2.

Resource use, costs, and approval times for planning and preparing a randomized clinical trial before and after the implementation of the new Swiss human research legislation.

Speich B, Schur N, Gryaznov D, von Niederhäusern B, Hemkens LG, Schandelmaier S, Amstutz A, Kasenda B, Pauli-Magnus C, Ojeda-Ruiz E, Tomonaga Y, McCord K, Nordmann A, von Elm E, Briel M, Schwenkglenks M; a collaboration of the MARTA (MAking Randomized Trials Affordable) and ASPIRE (Adherence to Standard Protocol Items: REcommendations for interventional trials) Study Groups.

PLoS One. 2019 Jan 11;14(1):e0210669. doi: 10.1371/journal.pone.0210669. eCollection 2019.

3.

Population-Based Linkage of Big Data in Dental Research.

Joda T, Waltimo T, Pauli-Magnus C, Probst-Hensch N, Zitzmann NU.

Int J Environ Res Public Health. 2018 Oct 25;15(11). pii: E2357. doi: 10.3390/ijerph15112357. Review.

4.

Academic response to improving value and reducing waste: A comprehensive framework for INcreasing QUality In patient-oriented academic clinical REsearch (INQUIRE).

von Niederhäusern B, Guyatt GH, Briel M, Pauli-Magnus C.

PLoS Med. 2018 Jun 7;15(6):e1002580. doi: 10.1371/journal.pmed.1002580. eCollection 2018 Jun.

5.

The impact of clinical trial units on the value of clinical research in Switzerland.

von Niederhäusern B, Magnin A, Pauli-Magnus C.

Swiss Med Wkly. 2018 Apr 26;148:w14615. doi: 10.4414/smw.2018.14615. eCollection 2018. Review.

6.

Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list.

Speich B, von Niederhäusern B, Blum CA, Keiser J, Schur N, Fürst T, Kasenda B, Christ-Crain M, Hemkens LG, Pauli-Magnus C, Schwenkglenks M, Briel M; MAking Randomized Trials Affordable (MARTA) Group.

J Clin Epidemiol. 2018 Apr;96:73-83. doi: 10.1016/j.jclinepi.2017.12.022. Epub 2017 Dec 30.

PMID:
29292203
7.

Systematic review on costs and resource use of randomized clinical trials shows a lack of transparent and comprehensive data.

Speich B, von Niederhäusern B, Schur N, Hemkens LG, Fürst T, Bhatnagar N, Alturki R, Agarwal A, Kasenda B, Pauli-Magnus C, Schwenkglenks M, Briel M; MAking Randomized Trials Affordable (MARTA) Group.

J Clin Epidemiol. 2018 Apr;96:1-11. doi: 10.1016/j.jclinepi.2017.12.018. Epub 2017 Dec 27. Review.

PMID:
29288136
8.

Validity of mobile electronic data capture in clinical studies: a pilot study in a pediatric population.

von Niederhäusern B, Saccilotto R, Schädelin S, Ziesenitz V, Benkert P, Decker ML, Hammann A, Bielicki J, Pfister M, Pauli-Magnus C.

BMC Med Res Methodol. 2017 Dec 8;17(1):163. doi: 10.1186/s12874-017-0438-x.

9.

Towards the development of a comprehensive framework: Qualitative systematic survey of definitions of clinical research quality.

von Niederhäusern B, Schandelmaier S, Mi Bonde M, Brunner N, Hemkens LG, Rutquist M, Bhatnagar N, Guyatt GH, Pauli-Magnus C, Briel M.

PLoS One. 2017 Jul 17;12(7):e0180635. doi: 10.1371/journal.pone.0180635. eCollection 2017.

10.

Generating evidence on a risk-based monitoring approach in the academic setting - lessons learned.

von Niederhäusern B, Orleth A, Schädelin S, Rawi N, Velkopolszky M, Becherer C, Benkert P, Satalkar P, Briel M, Pauli-Magnus C.

BMC Med Res Methodol. 2017 Feb 14;17(1):26. doi: 10.1186/s12874-017-0308-6.

11.

The role of Clinical Trial Units in investigator- and industry-initiated research projects.

von Niederhäusern B, Fabbro T, Pauli-Magnus C.

Swiss Med Wkly. 2015 Jul 2;145:w14161. doi: 10.4414/smw.2015.14161. eCollection 2015.

12.

A European approach to clinical investigator training.

Boeynaems JM, Canivet C, Chan A, Clarke MJ, Cornu C, Daemen E, Demotes J, Nys KD, Hirst B, Hundt F, Kassai B, Kerpel-Fronius S, Kiessig L, Klech H, Kraehenbuhl JP, Lafolie P, Lucht M, Niese D, Pauli-Magnus C, Peters B, Schaltenbrand R, Stockis A, Stykova M, Verheus N, Klingmann I.

Front Pharmacol. 2013 Sep 9;4:112. doi: 10.3389/fphar.2013.00112. Review.

13.

Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy.

Pauli-Magnus C, Meier PJ, Stieger B.

Semin Liver Dis. 2010 May;30(2):147-59. doi: 10.1055/s-0030-1253224. Epub 2010 Apr 26. Review.

14.

Effect of ritonavir on the pharmacokinetics of the benzimidazoles albendazole and mebendazole: an interaction study in healthy volunteers.

Corti N, Heck A, Rentsch K, Zingg W, Jetter A, Stieger B, Pauli-Magnus C.

Eur J Clin Pharmacol. 2009 Oct;65(10):999-1006. doi: 10.1007/s00228-009-0683-y. Epub 2009 Jun 27.

PMID:
19562329
15.

Systemic prokinetic pharmacologic treatment for postoperative adynamic ileus following abdominal surgery in adults.

Traut U, Brügger L, Kunz R, Pauli-Magnus C, Haug K, Bucher HC, Koller MT.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD004930. doi: 10.1002/14651858.CD004930.pub3. Review.

PMID:
18254064
16.

Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump.

Meier Y, Zodan T, Lang C, Zimmermann R, Kullak-Ublick GA, Meier PJ, Stieger B, Pauli-Magnus C.

World J Gastroenterol. 2008 Jan 7;14(1):38-45.

17.

Intestinal expression of cytochrome P450 enzymes and ABC transporters and carbamazepine and phenytoin disposition.

Simon C, Stieger B, Kullak-Ublick GA, Fried M, Mueller S, Fritschy JM, Wieser HG, Pauli-Magnus C.

Acta Neurol Scand. 2007 Apr;115(4):232-42.

PMID:
17376120
18.

Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury.

Lang C, Meier Y, Stieger B, Beuers U, Lang T, Kerb R, Kullak-Ublick GA, Meier PJ, Pauli-Magnus C.

Pharmacogenet Genomics. 2007 Jan;17(1):47-60.

PMID:
17264802
19.

Hepatobiliary transporters and drug-induced cholestasis.

Pauli-Magnus C, Meier PJ.

Hepatology. 2006 Oct;44(4):778-87. Review.

PMID:
17006912
20.

Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver.

Meier Y, Pauli-Magnus C, Zanger UM, Klein K, Schaeffeler E, Nussler AK, Nussler N, Eichelbaum M, Meier PJ, Stieger B.

Hepatology. 2006 Jul;44(1):62-74.

PMID:
16799996
21.

The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients.

Kimmel M, Alscher DM, Dunst R, Braun N, Machleidt C, Kiefer T, Stülten C, van der Kuip H, Pauli-Magnus C, Raub U, Kuhlmann U, Mettang T.

Nephrol Dial Transplant. 2006 Mar;21(3):749-55. Epub 2005 Oct 25.

PMID:
16249205
22.

Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis.

Noe J, Kullak-Ublick GA, Jochum W, Stieger B, Kerb R, Haberl M, Müllhaupt B, Meier PJ, Pauli-Magnus C.

J Hepatol. 2005 Sep;43(3):536-43.

PMID:
16039748
23.

Enterohepatic transport of bile salts and genetics of cholestasis.

Pauli-Magnus C, Stieger B, Meier Y, Kullak-Ublick GA, Meier PJ.

J Hepatol. 2005 Aug;43(2):342-57. Review. No abstract available.

PMID:
15975683
24.

Hepatocellular transporters and cholestasis.

Pauli-Magnus C, Meier PJ.

J Clin Gastroenterol. 2005 Apr;39(4 Suppl 2):S103-10. Review.

PMID:
15758645
25.

Incidence of drug-induced liver injury in medical inpatients.

Meier Y, Cavallaro M, Roos M, Pauli-Magnus C, Folkers G, Meier PJ, Fattinger K.

Eur J Clin Pharmacol. 2005 Apr;61(2):135-43. Epub 2005 Feb 23.

PMID:
15726344
26.

Alveolar echinococcosis of the liver in an adult with human immunodeficiency virus type-1 infection.

Zingg W, Renner-Schneiter EC, Pauli-Magnus C, Renner EL, van Overbeck J, Schläpfer E, Weber M, Weber R, Opravil M, Gottstein B, Speck RF; Swiss HIV Cohort Study.

Infection. 2004 Oct;32(5):299-302.

PMID:
15624896
27.

Adverse drug events caused by medication errors in medical inpatients.

Hardmeier B, Braunschweig S, Cavallaro M, Roos M, Pauli-Magnus C, Giger M, Meier PJ, Fattinger K.

Swiss Med Wkly. 2004 Nov 13;134(45-46):664-70.

28.

Functional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1).

Pauli-Magnus C, Kroetz DL.

Pharm Res. 2004 Jun;21(6):904-13. Review.

PMID:
15212152
29.

Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy.

Pauli-Magnus C, Lang T, Meier Y, Zodan-Marin T, Jung D, Breymann C, Zimmermann R, Kenngott S, Beuers U, Reichel C, Kerb R, Penger A, Meier PJ, Kullak-Ublick GA.

Pharmacogenetics. 2004 Feb;14(2):91-102.

PMID:
15077010
30.

BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis.

Pauli-Magnus C, Kerb R, Fattinger K, Lang T, Anwald B, Kullak-Ublick GA, Beuers U, Meier PJ.

Hepatology. 2004 Mar;39(3):779-91.

PMID:
14999697
31.

Fatal liver failure with atorvastatin.

Perger L, Kohler M, Fattinger K, Flury R, Meier PJ, Pauli-Magnus C.

J Hepatol. 2003 Dec;39(6):1095-7. No abstract available.

PMID:
14642636
32.

No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects.

Pauli-Magnus C, Feiner J, Brett C, Lin E, Kroetz DL.

Clin Pharmacol Ther. 2003 Nov;74(5):487-98.

PMID:
14586389
33.

Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts.

Girardin F, Rentsch KM, Schwab MA, Maggiorini M, Pauli-Magnus C, Kullak-Ublick GA, Meier PJ, Fattinger K.

Clin Pharmacol Ther. 2003 Oct;74(4):341-52.

PMID:
14534521
34.

Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene.

Kroetz DL, Pauli-Magnus C, Hodges LM, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE, DeYoung J, Taylor T, Carlson EJ, Herskowitz I, Giacomini KM, Clark AG; Pharmacogenetics of Membrane Transporters Investigators.

Pharmacogenetics. 2003 Aug;13(8):481-94. Erratum in: Pharmacogenetics. 2003 Nov;13(11):701.

PMID:
12893986
35.

Pharmacogenetics of hepatocellular transporters.

Pauli-Magnus C, Meier PJ.

Pharmacogenetics. 2003 Apr;13(4):189-98. Review.

PMID:
12668915
36.

Progressive changes in patients' lives after psychotherapy: which treatment effects support them?

Grande T, Rudolf G, Oberbracht C, Pauli-Magnus C.

Psychother Res. 2003 Mar;13(1):43-58. doi: 10.1093/ptr/kpg006.

PMID:
22475162
37.

Uraemic pruritus--new perspectives and insights from recent trials.

Mettang T, Pauli-Magnus C, Alscher DM.

Nephrol Dial Transplant. 2002 Sep;17(9):1558-63. Review. No abstract available.

PMID:
12198205
38.

MDR1 reference sequence and reference function.

Pauli-Magnus C, Kroetz DL.

Clin Pharmacol Ther. 2002 Jul;72(1):100-1. No abstract available.

PMID:
12152008
39.

Containers for waste causing peritonitis in CAPD patients.

Alscher DM, Pfinder-Nohe E, Rumpf D, Pauli-Magnus C, Knabbe C, Kuhlmann U, Mettang T, Krankenhaus RB.

EDTNA ERCA J. 2001 Jul-Sep;27(3):140-2, 146.

PMID:
11868996
40.

[Typical counseling processes in prenatal diagnosis--an explorative study].

Pauli-Magnus C, Dewald A, Cierpka M.

Prax Kinderpsychol Kinderpsychiatr. 2001 Nov-Dec;50(9-10):771-85. German.

PMID:
11810969
41.

Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein.

Pauli-Magnus C, Rekersbrink S, Klotz U, Fromm MF.

Naunyn Schmiedebergs Arch Pharmacol. 2001 Dec;364(6):551-7.

PMID:
11770010
42.

P-glycoprotein-mediated transport of digitoxin, alpha-methyldigoxin and beta-acetyldigoxin.

Pauli-Magnus C, Mürdter T, Godel A, Mettang T, Eichelbaum M, Klotz U, Fromm MF.

Naunyn Schmiedebergs Arch Pharmacol. 2001 Mar;363(3):337-43.

PMID:
11284449
43.

Short-term efficacy of tacrolimus ointment in severe uremic pruritus.

Pauli-Magnus C, Klumpp S, Alscher DM, Kuhlmann U, Mettang T.

Perit Dial Int. 2000 Nov-Dec;20(6):802-3. No abstract available.

PMID:
11216583
44.

Pruritus and anemia in a patient on peritoneal dialysis--pitfalls in diagnosis for common symptoms.

Mettang T, Schwab M, Pauli-Magnus C, Alscher DM, Kuhlmann U.

Perit Dial Int. 2000 Nov-Dec;20(6):785-7. No abstract available.

PMID:
11216576
45.

The pathophysiological puzzle of uremic pruritus--insights and speculations from therapeutic and epidemiological studies.

Mettang T, Pauli-Magnus C.

Perit Dial Int. 2000 Sep-Oct;20(5):493-4. No abstract available.

PMID:
11117239
46.
47.
48.

"Sick-bag" syndrome.

Mettang T, Pauli-Magnus C, Kuhlmann U.

Perit Dial Int. 2000 Mar-Apr;20(2):243. No abstract available.

PMID:
10809254
49.

Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein.

Pauli-Magnus C, von Richter O, Burk O, Ziegler A, Mettang T, Eichelbaum M, Fromm MF.

J Pharmacol Exp Ther. 2000 May;293(2):376-82.

PMID:
10773005
50.

Influence of plasticizer-free CAPD bags and tubings on serum, urine, and dialysate levels of phthalic acid esters in CAPD patients.

Mettang T, Pauli-Magnus C, Alscher DM, Kirchgessner J, Wodarz R, Rettenmeier AW, Kuhlmann U.

Perit Dial Int. 2000 Jan-Feb;20(1):80-4.

PMID:
10716589

Supplemental Content

Loading ...
Support Center